What Happened to Humana Inc.?

Humana Inc. has a long history of evolution within the healthcare sector, starting as a nursing home company in 1961 before transitioning to hospital ownership and eventually becoming a major health insurance provider, with a strong emphasis on government-sponsored programs like Medicare Advantage (MA) and Medicaid. In recent years, Humana has faced significant challenges, particularly concerning its Medicare Advantage business. A notable turning point was the decline in its Medicare Star Ratings for 2025, which reduced the number of members in 4-star or higher plans from 94% in 2024 to 25% for 2025, impacting quality bonus payments for 2026. This, coupled with an elevated medical cost trend, has put pressure on the company's profitability.

In response to these pressures, Humana has embarked on a strategic pivot under CEO Jim Rechtin, prioritizing margin recovery over aggressive membership growth. The company's primary goal is to achieve a sustainable 3% Medicare Advantage margin by 2028, with meaningful progress expected in 2027. This strategy entails making adjustments to Medicare Advantage benefits for the 2027 plan year, a move that other major insurers had already undertaken. While these adjustments are designed to be thoughtful and minimize impact on members, they are necessary to address the widening gap between CMS funding and the cost of care.

Despite the profitability challenges, Humana has demonstrated robust top-line growth. For the first quarter of 2026, the company reported revenues of $39.6 billion, a 23.5% increase year-over-year, driven by substantial growth in Medicare Advantage membership. Humana added 1.3 million MA members in Q1 2026, bringing its total to 7.1 million, making it the only major national insurer to grow enrollment significantly in the past year. This growth, however, comes with the caveat of newer members initially incurring higher medical costs, contributing to the elevated benefit ratio.

Humana's CenterWell segment, which includes senior-focused primary care, home health, and pharmacy services, remains a crucial part of its long-term strategy for value-based care. This segment saw significant patient growth in 2025 and Q1 2026, partly due to acquisitions like MaxHealth. The company views CenterWell as integral to improving patient outcomes and managing costs, creating a 'virtuous cycle' with its insurance offerings. As of May 8, 2026, Humana is actively preparing its 2027 Medicare Advantage bids, balancing member benefits with the imperative of margin recovery, while continuing to expand its integrated care delivery model.